DURAK, A. Et Al. 2022. Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction. Clinical and Experimental Pharmacology and Physiology , vol.49, no.1 , 46-59.

DURAK, A., AKKUŞ, E., GÖKÇAY CANPOLAT, A., TUNCAY, E., ÇORAPÇIOĞLU, D., & Turan, B., (2022). Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction. Clinical and Experimental Pharmacology and Physiology , vol.49, no.1, 46-59.

DURAK, AYŞEGÜL Et Al. "Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction," Clinical and Experimental Pharmacology and Physiology , vol.49, no.1, 46-59, 2022

DURAK, AYŞEGÜL Et Al. "Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction." Clinical and Experimental Pharmacology and Physiology , vol.49, no.1, pp.46-59, 2022

DURAK, A. Et Al. (2022) . "Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction." Clinical and Experimental Pharmacology and Physiology , vol.49, no.1, pp.46-59.

@article{article, author={AYŞEGÜL DURAK Et Al. }, title={Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunction}, journal={Clinical and Experimental Pharmacology and Physiology}, year=2022, pages={46-59} }